Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
The European Treatment and Outcome Study for CML (EUTOS for CML) is a unique scientific collaboration between the European LeukemiaNet (ELN) and Novartis. It aims to use the strengths of the two organizations – the clinical expertise and experience of the ELN, allied to Novartis’ outreach potential and funding provision – to help physicians optimize the treatment of CML.
